Charter Research & Investment Group, Inc. Abb Vie Inc. Transaction History
Charter Research & Investment Group, Inc.
- $126 Million
- Q1 2024
A detailed history of Charter Research & Investment Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Charter Research & Investment Group, Inc. holds 5,684 shares of ABBV stock, worth $1.05 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
5,684
Previous 6,034
5.8%
Holding current value
$1.05 Million
Previous $935,000
10.7%
% of portfolio
0.82%
Previous 0.78%
Shares
10 transactions
Others Institutions Holding ABBV
# of Institutions
3,647Shares Held
1.23BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$31.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$26.5 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$14.4 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$9.49 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.91 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $327B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...